Vitrolife AB Stock Nasdaq Stockholm
Stocks
SE0000816043
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 12.53B 1.25B 1.1B 1.04B 947M 1.78B 120B 1.79B 4.83B 61.28B 4.7B 4.59B 197B | P/E 2026 * |
25.4x | P/E 2027 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 13.08B 1.31B 1.15B 1.09B 988M 1.85B 125B 1.87B 5.04B 63.96B 4.9B 4.8B 206B | EV / Sales 2026 * |
3.78x | EV / Sales 2027 * | 3.37x |
| Free-Float |
54.39% | Yield 2026 * |
1.2% | Yield 2027 * | 1.36% |
Last Transcript: Vitrolife AB
| 1 day | -0.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Bronwyn O'Connor
CEO | Chief Executive Officer | 52 | 2023-07-31 |
Pär Ihrskog
DFI | Director of Finance/CFO | 55 | 2025-10-09 |
Nicklas Hansen
CIO | Chief Investment Officer | 40 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Pia Marions
BRD | Director/Board Member | 63 | 2013-04-18 |
| Chairman | 70 | 2023-07-31 | |
| Chairman | 55 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.18% | -6.68% | - | - | 1.26B | ||
| -0.62% | -0.39% | +184.67% | +495.36% | 23.8B | ||
| +1.34% | +11.28% | +691.93% | +117.71% | 11.53B | ||
| -1.19% | +7.51% | -29.94% | -14.23% | 10.67B | ||
| -1.83% | -0.99% | +3.87% | - | 8.97B | ||
| -0.15% | -0.37% | +96.82% | +43.39% | 6.51B | ||
| -0.08% | +1.06% | -27.44% | -21.96% | 5.81B | ||
| -0.98% | +3.05% | +4.25% | -9.16% | 4.46B | ||
| +1.96% | -5.39% | +56.56% | +61.68% | 3.7B | ||
| -1.52% | +3.35% | -14.61% | -26.50% | 2.9B | ||
| Average | -0.36% | +2.10% | +107.35% | +80.79% | 8.71B | |
| Weighted average by Cap. | -0.46% | +3.78% | +162.68% | +191.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 345M 305M 288M 261M 490M 33.12B 495M 1.33B 16.91B 1.3B 1.27B 54.43B | 3.71B 370M 327M 309M 280M 525M 35.51B 531M 1.43B 18.13B 1.39B 1.36B 58.36B |
| Net income | 493M 49.17M 43.39M 41.06M 37.23M 69.81M 4.72B 70.49M 190M 2.41B 185M 181M 7.75B | 609M 60.77M 53.63M 50.74M 46.02M 86.28M 5.83B 87.13M 235M 2.98B 228M 223M 9.58B |
| Net Debt | 549M 54.81M 48.37M 45.77M 41.51M 77.82M 5.26B 78.58M 212M 2.69B 206M 201M 8.64B | -26.74M -2.67M -2.36M -2.23M -2.02M -3.79M -256M -3.83M -10.3M -131M -10.02M -9.81M -421M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















